-
Founded in:
2003-04-02 -
Country:
China -
Address:
Hanyu Innovation Industry Building, No. 7 Guansheng 4th Road, Guanlan High-tech Park, Longhua District, Shenzhen -
Tax NO.:
91440300748855818E -
Registered Funds:
883.241336 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium ferulic |
This product is a non-peptide endothelin receptor antagonist, which can antagonize endothelin-induced vasoconstriction, blood pressure increase and vascular smooth muscle cell proliferation, reduce vascular endothelial damage; increase NO synthesis, relax vascular smooth muscle; inhibit platelet aggregation, anti-coagulation, and improve blood rheology characteristics. This product can also inhibit cholesterol synthesis, lower blood lipids, scavenge free radicals, prevent lipid peroxidation damage; affect complement, enhance immune function, and have certain analgesic and antispasmodic effects.
More
This product is a non-peptide endothelin receptor antagonist, which can antagonize endothelin-induced vasoconstriction, blood pressure increase and vascular smooth muscle cell proliferation, reduce vascular endothelial damage; increase NO synthesis, relax vascular smooth muscle; inhibit platelet aggregation, anti-coagulation, and improve blood rheology characteristics. This product can also inhibit cholesterol synthesis, lower blood lipids, scavenge free radicals, prevent lipid peroxidation damage; affect complement, enhance immune function, and have certain analgesic and antispasmodic effects. |
24276-84-4 | 8 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium ferulic |
This product is a non-peptide endothelin receptor antagonist, which can antagonize endothelin-induced vasoconstriction, blood pressure increase and vascular smooth muscle cell proliferation, reduce vascular endothelial damage; increase NO synthesis, relax vascular smooth muscle; inhibit platelet aggregation, anti-coagulation, and improve blood rheology characteristics. This product can also inhibit cholesterol synthesis, lower blood lipids, scavenge free radicals, prevent lipid peroxidation damage; affect complement, enhance immune function, and have certain analgesic and antispasmodic effects.
More
This product is a non-peptide endothelin receptor antagonist, which can antagonize endothelin-induced vasoconstriction, blood pressure increase and vascular smooth muscle cell proliferation, reduce vascular endothelial damage; increase NO synthesis, relax vascular smooth muscle; inhibit platelet aggregation, anti-coagulation, and improve blood rheology characteristics. This product can also inhibit cholesterol synthesis, lower blood lipids, scavenge free radicals, prevent lipid peroxidation damage; affect complement, enhance immune function, and have certain analgesic and antispasmodic effects. |
24276-84-4 | 8 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium ferulic |
This product is a non-peptide endothelin receptor antagonist, which can antagonize endothelin-induced vasoconstriction, blood pressure increase and vascular smooth muscle cell proliferation, reduce vascular endothelial damage; increase NO synthesis, relax vascular smooth muscle; inhibit platelet aggregation, anti-coagulation, and improve blood rheology characteristics. This product can also inhibit cholesterol synthesis, lower blood lipids, scavenge free radicals, prevent lipid peroxidation damage; affect complement, enhance immune function, and have certain analgesic and antispasmodic effects.
More
This product is a non-peptide endothelin receptor antagonist, which can antagonize endothelin-induced vasoconstriction, blood pressure increase and vascular smooth muscle cell proliferation, reduce vascular endothelial damage; increase NO synthesis, relax vascular smooth muscle; inhibit platelet aggregation, anti-coagulation, and improve blood rheology characteristics. This product can also inhibit cholesterol synthesis, lower blood lipids, scavenge free radicals, prevent lipid peroxidation damage; affect complement, enhance immune function, and have certain analgesic and antispasmodic effects. |
24276-84-4 | 8 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Somatostatin |
Inhibits the secretion of growth hormone, thyroid stimulating hormone, insulin and glucagon, and inhibits the secretion of gastric acid; affects the absorption, motility, visceral blood flow and nutritional function of the gastrointestinal tract; inhibits the secretion of gastrin, gastric acid and pepsin, thereby treating upper gastrointestinal bleeding; significantly reduces the blood flow to visceral organs without causing significant changes in systemic arterial blood pressure, and has certain value in the treatment of esophageal varicose bleeding; reduces the endocrine and exocrine secretions of the pancreas.
More
Inhibits the secretion of growth hormone, thyroid stimulating hormone, insulin and glucagon, and inhibits the secretion of gastric acid; affects the absorption, motility, visceral blood flow and nutritional function of the gastrointestinal tract; inhibits the secretion of gastrin, gastric acid and pepsin, thereby treating upper gastrointestinal bleeding; significantly reduces the blood flow to visceral organs without causing significant changes in systemic arterial blood pressure, and has certain value in the treatment of esophageal varicose bleeding; reduces the endocrine and exocrine secretions of the pancreas. |
51110-01-1 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Somatostatin |
Inhibits the secretion of growth hormone, thyroid stimulating hormone, insulin and glucagon, and inhibits the secretion of gastric acid; affects the absorption, motility, visceral blood flow and nutritional function of the gastrointestinal tract; inhibits the secretion of gastrin, gastric acid and pepsin, and is used to treat upper gastrointestinal bleeding; reduces the blood flow to visceral organs without significantly changing the systemic arterial blood pressure, and is suitable for the treatment of esophageal varicose bleeding; reduces the endocrine and related functions of the pancreas.
More
Inhibits the secretion of growth hormone, thyroid stimulating hormone, insulin and glucagon, and inhibits the secretion of gastric acid; affects the absorption, motility, visceral blood flow and nutritional function of the gastrointestinal tract; inhibits the secretion of gastrin, gastric acid and pepsin, and is used to treat upper gastrointestinal bleeding; reduces the blood flow to visceral organs without significantly changing the systemic arterial blood pressure, and is suitable for the treatment of esophageal varicose bleeding; reduces the endocrine and related functions of the pancreas. |
51110-01-1 | 28 |